Literature DB >> 21882964

Rapidly progressive, fatal, inhalation anthrax-like infection in a human: case report, pathogen genome sequencing, pathology, and coordinated response.

Angela M Wright1, Stephen B Beres, Erin N Consamus, S Wesley Long, Anthony R Flores, Roberto Barrios, G Stefan Richter, So-Young Oh, Gabriella Garufi, Hannah Maier, Ashley L Drews, Kathryn E Stockbauer, Patricia Cernoch, Olaf Schneewind, Randall J Olsen, James M Musser.   

Abstract

CONTEXT: Ten years ago a bioterrorism event involving Bacillus anthracis spores captured the nation's interest, stimulated extensive new research on this pathogen, and heightened concern about illegitimate release of infectious agents. Sporadic reports have described rare, fulminant, and sometimes fatal cases of pneumonia in humans and nonhuman primates caused by strains of Bacillus cereus , a species closely related to Bacillus anthracis.
OBJECTIVES: To describe and investigate a case of rapidly progressive, fatal, anthrax-like pneumonia and the overwhelming infection caused by a Bacillus species of uncertain provenance in a patient residing in rural Texas.
DESIGN: We characterized the genome of the causative strain within days of its recovery from antemortem cultures using next-generation sequencing and performed immunohistochemistry on tissues obtained at autopsy with antibodies directed against virulence proteins of B anthracis and B cereus.
RESULTS: We discovered that the infection was caused by a previously unknown strain of B cereus that was closely related to, but genetically distinct from, B anthracis . The strain contains a plasmid similar to pXO1, a genetic element encoding anthrax toxin and other known virulence factors. Immunohistochemistry demonstrated that several homologs of B anthracis virulence proteins were made in infected tissues, likely contributing to the patient's death.
CONCLUSIONS: Rapid genome sequence analysis permitted us to genetically define this strain, rule out the likelihood of bioterrorism, and contribute effectively to the institutional response to this event. Our experience strongly reinforced the critical value of deploying a well-integrated, anatomic, clinical, and genomic strategy to respond rapidly to a potential emerging, infectious threat to public health.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21882964     DOI: 10.5858/2011-0362-SAIR.1

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  24 in total

1.  Phase 1 study of a recombinant mutant protective antigen of Bacillus anthracis.

Authors:  Joseph A Bellanti; Feng-Ying C Lin; Chiayung Chu; Joseph Shiloach; Stephen H Leppla; German A Benavides; Arthur Karpas; Mahtab Moayeri; Chunyan Guo; John B Robbins; Rachel Schneerson
Journal:  Clin Vaccine Immunol       Date:  2011-12-21

2.  A genomic day in the life of a clinical microbiology laboratory.

Authors:  S Wesley Long; Dawn Williams; Chandni Valson; Concepcion C Cantu; Patricia Cernoch; James M Musser; Randall J Olsen
Journal:  J Clin Microbiol       Date:  2013-01-23       Impact factor: 5.948

3.  Clinical laboratory response to a mock outbreak of invasive bacterial infections: a preparedness study.

Authors:  Randall J Olsen; Nahuel Fittipaldi; Priyanka Kachroo; Misu A Sanson; S Wesley Long; Kathryn J Como-Sabetti; Chandni Valson; Concepcion Cantu; Ruth Lynfield; Chris Van Beneden; Stephen B Beres; James M Musser
Journal:  J Clin Microbiol       Date:  2014-09-24       Impact factor: 5.948

Review 4.  The Bacillus cereus Group: Bacillus Species with Pathogenic Potential.

Authors:  Monika Ehling-Schulz; Didier Lereclus; Theresa M Koehler
Journal:  Microbiol Spectr       Date:  2019-05

Review 5.  Assembly and Function of the Bacillus anthracis S-Layer.

Authors:  Dominique Missiakas; Olaf Schneewind
Journal:  Annu Rev Microbiol       Date:  2017-09-08       Impact factor: 15.500

Review 6.  Progress and potential: training in genomic pathology.

Authors:  Richard L Haspel; Randall J Olsen; Anna Berry; Charles E Hill; John D Pfeifer; Iris Schrijver; Karen L Kaul
Journal:  Arch Pathol Lab Med       Date:  2014-04       Impact factor: 5.534

7.  The roles of AtxA orthologs in virulence of anthrax-like Bacillus cereus G9241.

Authors:  Jennifer M Scarff; Malik J Raynor; Yuliya I Seldina; Christy L Ventura; Theresa M Koehler; Alison D O'Brien
Journal:  Mol Microbiol       Date:  2016-09-04       Impact factor: 3.501

8.  Vaccine protection against Bacillus cereus-mediated respiratory anthrax-like disease in mice.

Authors:  So-Young Oh; Hannah Maier; Jay Schroeder; G Stefan Richter; Derek Elli; James M Musser; Lauriane E Quenee; Dominique M Missiakas; Olaf Schneewind
Journal:  Infect Immun       Date:  2013-01-14       Impact factor: 3.441

9.  Certhrax Is an Antivirulence Factor for the Anthrax-Like Organism Bacillus cereus Strain G9241.

Authors:  Yuliya I Seldina; Courtney D Petro; Stephanie L Servetas; James M Vergis; Christy L Ventura; D Scott Merrell; Alison D O'Brien
Journal:  Infect Immun       Date:  2018-05-22       Impact factor: 3.441

10.  On the evolutionary history, population genetics and diversity among isolates of Salmonella Enteritidis PFGE pattern JEGX01.0004.

Authors:  Marc W Allard; Yan Luo; Errol Strain; James Pettengill; Ruth Timme; Charles Wang; Cong Li; Christine E Keys; Jie Zheng; Robert Stones; Mark R Wilson; Steven M Musser; Eric W Brown
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.